Novel Brain Organoids Show Promise in Predicting Alzheimer’s Drug Response and Guiding Personalized Treatment Strategies

Scientists at Johns Hopkins Medicine have uncovered groundbreaking evidence suggesting that miniature clusters of brain tissue, cultivated from the cells of individuals with Alzheimer’s disease, can serve as a critical…

New Alzheimer’s drug repairs DNA damage and reduces brain inflammation

Researchers at King’s College London have identified a promising new strategy for tackling Alzheimer’s disease by targeting several of the disease’s earliest biological changes at the same time. Their study…

A Constipation Drug Shows Promise in Alleviating Lingering Cognitive Symptoms of Depression

People who have experienced depression often find themselves grappling with persistent cognitive challenges, commonly referred to as "brain fog," which can manifest as memory problems and a marked decline in…

An international mega-analysis of psychedelic drug effects on brain circuit function

A comprehensive international analysis combining brain imaging data from multiple independent studies has identified a definitive and common pattern in how psychedelic drugs alter communication between different brain networks. Published…

Redefining Drug Immune Recognition: A Radically Reconfigured Molecular Architecture Enables Broad Fentanyl-Class Protection

The escalating crisis of fentanyl-related synthetic opioid overdoses, a public health emergency claiming more American lives annually than motor vehicle accidents and gun violence combined, is spurring innovative scientific endeavors.…

The Anti-Aging Drug Combination Dasatinib-Quercetin Shows Troubling Brain Damage in Mice, Casting Shadow on Longevity Research

A widely explored drug combination, celebrated for its potential to combat aging by clearing senescent cells, has revealed a significant and concerning side effect: substantial brain damage in mice. Researchers…

Clinical trial suggests an anti-inflammatory drug could relieve difficult-to-treat depression

The Limitations of the Monoamine Hypothesis For decades, the pharmacological treatment of major depressive disorder (MDD) has been dominated by the monoamine hypothesis. This theory posits that depression is primarily…

The Promising Anti-Aging Drug Combination Dasatinib-Quercetin Linked to Significant Brain Damage in Mice

A widely investigated drug combination, lauded for its potential to combat aging, has revealed a serious and concerning downside: significant brain damage in laboratory mice. Researchers at the University of…

NIH Researchers Uncover Crucial Intracellular Mechanisms Driving GLP-1 Weight Loss Drug Efficacy and Variability

Researchers at the National Institutes of Health (NIH) have made significant strides in understanding the intricate internal signaling processes within brain cells that govern the effectiveness of GLP-1 weight loss…

Weight loss drug Ozempic linked to lower depression and anxiety risk

A landmark study has unveiled a surprising and potentially transformative aspect of medications commonly prescribed for type 2 diabetes and obesity. Drugs like Ozempic and Wegovy, belonging to the class…